3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Neuroblastoma
1
Lymphoma, Large B-Cell, Diffuse
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Biliary Tract Neoplasms
1
Interventions
pembrolizumab
65
Nivolumab
56
Ipilimumab
34
Specimen Handling
23
Magnetic Resonance Spectroscopy
21
Cyclophosphamide
17
Biopsy
13
Radiosurgery
12
relatlimab
11
fludarabine
11
binimetinib
11
Opdualag
11
CTLA-4 Antigen
11
trametinib
10
fludarabine phosphate
8
dabrafenib
8
lifileucel
7
encorafenib
7
aldesleukin
7
atezolizumab
6
Interleukin-2
6
cemiplimab
5
X-Rays
5
Paclitaxel
5
Immunoglobulin G
5
Blood Specimen Collection
5
Taxes
4
Radiotherapy
4
Pemetrexed
4
Gemcitabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Antibodies
×
90 days
×
Clear all
No trials found.